article thumbnail

Recombinant DNA technology and its impact on drug discovery: Podcast

Drug Discovery World

Recombinant production is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and antibodies to expedite the process of novel drug identification and validation, for example. . Listen here.

article thumbnail

Recombinant DNA technology and its impact on modern drug discovery

Drug Discovery World

Recombinant production is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and antibodies to expedite the process of novel drug identification and validation, for example. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Exploring the Miracle Antibody Drug Conjugate Technologies

Roots Analysis

With fourteen approved drugs and several drug candidates being evaluated under different stages of development, antibody drug conjugates (ADCs) are now recognized as a potent class of targeted therapeutics. In this context, the role of the linker molecule and the conjugation technology used is pivotal.

article thumbnail

Amivantamab by Johnson & Johnson for Colorectal Cancer: Likelihood of Approval

Pharmaceutical Technology

According to GlobalData, Phase I drugs for Colorectal Cancer have a 76% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Amivantamab’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks. Buy the report here.

article thumbnail

What Are Biopharmaceuticals?

Pharma Packaging Solutions

Biopharmaceuticals, also called biologics, are drug products that are manufactured using biological sources. Semi-Synthesized: Though the term “biologic” is accurate for the extracted materials listed above, it is more often used to describe therapeutics that are produced with recombinant DNA technology.

article thumbnail

What is the Difference Between Biologics and Biosimilars?

Pharma Packaging Solutions

Biologics are drug products that are manufactured using materials from living sources. There are a few common types of biologics, including extracted (taken directly from a living system), semi-synthesized (produced with recombinant DNA technology), vaccines, and gene therapies. Let’s talk about it. What are Biologics?

article thumbnail

The DDW Podcast: 2022 in review 

Drug Discovery World

You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts. In October 2022, DDW launched the In Conversation With series, in which DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. . DDW Highlights . Sitting Down With .